Page last updated: 2024-08-23

ng-nitroarginine methyl ester and ST Elevated Myocardial Infarction

ng-nitroarginine methyl ester has been researched along with ST Elevated Myocardial Infarction in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Böhm, F; Collado, A; Jiao, T; Jurga, J; Mahdi, A; Pernow, J; Saleh, N; Tengbom, J; Verouhis, D; Yang, J; Zhou, Z1

Other Studies

1 other study(ies) available for ng-nitroarginine methyl ester and ST Elevated Myocardial Infarction

ArticleYear
Erythrocytes from patients with ST-elevation myocardial infarction induce cardioprotection through the purinergic P2Y
    Basic research in cardiology, 2022, 09-16, Volume: 117, Issue:1

    Topics: Adenosine Triphosphate; Animals; Cyclic GMP-Dependent Protein Kinases; Erythrocytes; Humans; Myocardial Infarction; Myocardial Reperfusion Injury; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Purinergic P2 Receptor Antagonists; Rats; Receptors, Purinergic P2; Soluble Guanylyl Cyclase; ST Elevation Myocardial Infarction

2022